Fda

131 results

Richard Pops, chairman and chief executive officer of Alkermes. Photograph: Patrick Fallon/Bloomberg

Shares in Irish drug company Alkermes continued to slide as the company comes to terms with an FDA refusal to consider approval for a depression drug (...)

For as long as people have fallen ill, there have been others only too keen to exploit them. History is littered with charismatic hucksters and misgu(...)

The idea behind gene therapy sounds simple – a person is born with a version of a gene that causes a disease, so you deliver a new gene to resolve the(...)

An American panel of public health experts have concluded that vaping with e-cigarettes that contain nicotine can be addictive and that teenagers who (...)

Ryanair rose 1.3% to €15.15 on a day when it  continued to deal with industrial relations tensions

Major global stock markets were little changed on Wednesday, hovering near recent record highs, while US treasury yields held close to multi-month pea(...)

Eight out of the 10 largest medical device companies in the world – including Pfizer, Boston Scientific, Bayer and Medtronic – have substantial Irish operations

A healthy environment, allowing for both medical innovation and entrepreneurship to thrive, has been attentively nurtured through consistent governmen(...)

Microbiologists can go into a lot of different areas in the industry
Across the board demand

According to the most recent study carried out by the Expert Group on Future Skills Needs (EGFSN), the biopharmaceutical sector in Ireland, comprising(...)

Prof Joyce Tait of Innogen in Edinburgh: ‘It costs $2 billion –€1.72bn – and takes 15 years to develop a new drug’
Unshackling innovation

The burden of regulation may be preventing the development of disruptive innovation from basic research in life sciences. That will be the theme of th(...)

AventaMed co-founder John Vaughan, chairman Jack Cashman, co-founder and CEO Olive O’Driscoll and Bruce Clibborn of HBAN Boole Investment Syndicate. Photograph: Michael Mac Sweeney/Provision

AventaMed, a Cork-based medtech firm focused on simplifying surgical procedures, has secured a €1.8 million investment to enable the company to attain(...)

Greencore chief executive Patrick Coveney: the company said the recall was a “purely precautionary measure, as no finished products have been found to have listeria present and no confirmed illnesses have been reported”. Photograph: Cyril Byrne

Greencore shares fell by 7.2 per cent on Monday after it was forced to recall several product lines on foot of a listeria scare at its plant in Rhode (...)

  • « First
  • Prev
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next
  • Last »